Gujarat Alkalies and Chemicals Résultats passés
Passé contrôle des critères 0/6
Gujarat Alkalies and Chemicals's earnings have been declining at an average annual rate of -26.4%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 10.9% per year.
Informations clés
-26.4%
Taux de croissance des bénéfices
-26.4%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 17.7% |
| Taux de croissance des recettes | 10.9% |
| Rendement des fonds propres | -3.7% |
| Marge nette | -5.8% |
| Prochaine mise à jour des résultats | 07 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
Ventilation des recettes et des dépenses
Comment Gujarat Alkalies and Chemicals gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 38,711 | -2,242 | 2,672 | 0 |
| 31 Mar 24 | 38,066 | -2,368 | 3,228 | 0 |
| 31 Dec 23 | 39,431 | -1,196 | 3,090 | 0 |
| 30 Sep 23 | 41,450 | 827 | 3,083 | 0 |
| 30 Jun 23 | 43,010 | 1,616 | 2,586 | 0 |
| 31 Mar 23 | 45,165 | 4,096 | 2,989 | 0 |
| 31 Dec 22 | 45,199 | 5,593 | 3,031 | 0 |
| 30 Sep 22 | 44,721 | 6,735 | 3,072 | 0 |
| 30 Jun 22 | 41,706 | 6,875 | 3,187 | 0 |
| 31 Mar 22 | 37,587 | 5,598 | 3,114 | 0 |
| 31 Dec 21 | 32,887 | 3,737 | 2,749 | 0 |
| 30 Sep 21 | 28,638 | 2,056 | 2,631 | 0 |
| 30 Jun 21 | 26,763 | 1,971 | 2,335 | 0 |
| 31 Mar 21 | 24,295 | 1,657 | 2,637 | 0 |
| 31 Dec 20 | 23,797 | 1,425 | 2,879 | 0 |
| 30 Sep 20 | 23,851 | 1,688 | 2,886 | 0 |
| 30 Jun 20 | 24,456 | 2,051 | 2,429 | 0 |
| 31 Mar 20 | 27,246 | 3,321 | 2,656 | 0 |
| 31 Dec 19 | 29,235 | 4,896 | 2,316 | 0 |
| 30 Sep 19 | 30,842 | 5,930 | 2,250 | 0 |
| 30 Jun 19 | 31,571 | 6,657 | 2,097 | 0 |
| 31 Mar 19 | 31,614 | 6,902 | 2,288 | 0 |
| 31 Mar 18 | 24,521 | 5,345 | 2,186 | 0 |
| 31 Mar 17 | 20,674 | 3,073 | 1,926 | 0 |
| 31 Dec 16 | 20,710 | 3,382 | 1,923 | 0 |
| 30 Sep 16 | 20,559 | 3,052 | 1,883 | 0 |
| 30 Jun 16 | 20,082 | 2,637 | 1,637 | 0 |
| 31 Mar 16 | 19,958 | 2,196 | 1,866 | 0 |
| 31 Dec 15 | 19,159 | 2,033 | 2,174 | 14 |
| 30 Sep 15 | 19,061 | 2,140 | 2,110 | 14 |
| 30 Jun 15 | 19,261 | 2,149 | 1,686 | 0 |
| 31 Mar 15 | 19,481 | 2,279 | 1,905 | 0 |
| 31 Dec 14 | 19,566 | 1,963 | 2,071 | 10 |
| 30 Sep 14 | 20,103 | 2,056 | 2,159 | 10 |
| 30 Jun 14 | 19,766 | 2,047 | 1,584 | 0 |
| 31 Mar 14 | 18,961 | 1,850 | 2,061 | 10 |
| 31 Dec 13 | 18,634 | 2,010 | 1,973 | 9 |
Des revenus de qualité: 530001 is currently unprofitable.
Augmentation de la marge bénéficiaire: 530001 is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 530001 is unprofitable, and losses have increased over the past 5 years at a rate of 26.4% per year.
Accélération de la croissance: Unable to compare 530001's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: 530001 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.4%).
Rendement des fonds propres
ROE élevé: 530001 has a negative Return on Equity (-3.69%), as it is currently unprofitable.